【摘要】：目的針對首發(fā)癥狀僅表現(xiàn)為復(fù)視的重癥肌無力(MG)患者,改良原有新斯的明試驗(yàn)方法,為提高這類患者診斷準(zhǔn)確率及減少誤診提供參考。方法收集首發(fā)癥狀表現(xiàn)為復(fù)視的MG患者32例,疾病對照組10例,對受試者均進(jìn)行經(jīng)典新斯的明和改良新斯的明試驗(yàn)檢測,并對結(jié)果進(jìn)行統(tǒng)計分析。結(jié)果 (1)9例MG患者經(jīng)典新斯的明試驗(yàn)結(jié)果為陽性(28%,9/32),26例MG患者改良新斯的明試驗(yàn)結(jié)果為陽性(81%,26/32);(2)疾病對照組在兩種試驗(yàn)中陽性率均為0(0,0/10)。結(jié)論改良新斯的明試驗(yàn)對以復(fù)視為首發(fā)癥狀的MG患者輔助診斷價值較高,輔助診斷MG有一定臨床意義。
[Abstract]:Objective to improve the original neostigmine test method for (MG) patients with myasthenia gravis whose first symptom is only amblyopia, so as to provide reference for improving the diagnostic accuracy and reducing the misdiagnosis of these patients. Methods 32 patients with MG and 10 patients with disease control were collected. The classical neostigmine test and modified neostigmine test were performed in all the subjects, and the results were statistically analyzed. Results (1) the results of classical neostigmine test in 9 patients with MG were positive (28%, 9 鈮，

本文編號：2476427